Omnicell (OMCL) Competitors

Masimo (NASDAQ:MASI) and Omnicell (NASDAQ:OMCL) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Which has more volatility and risk, MASI or OMCL?

Masimo has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of MASI or OMCL?

86.0% of Masimo shares are held by institutional investors. Comparatively, 97.7% of Omnicell shares are held by institutional investors. 16.9% of Masimo shares are held by insiders. Comparatively, 2.5% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Do analysts rate MASI or OMCL?

Masimo currently has a consensus target price of $194.60, suggesting a potential upside of 31.19%. Omnicell has a consensus target price of $46.71, suggesting a potential upside of 50.79%. Given Omnicell's higher probable upside, analysts clearly believe Omnicell is more favorable than Masimo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Masimo	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75
Omnicell	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

Does the media refer more to MASI or OMCL?

In the previous week, Masimo had 5 more articles in the media than Omnicell. MarketBeat recorded 7 mentions for Masimo and 2 mentions for Omnicell. Masimo's average media sentiment score of 1.07 beat Omnicell's score of 1.00 indicating that Masimo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Masimo	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omnicell	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MASI or OMCL more profitable?

Omnicell has a net margin of 2.01% compared to Masimo's net margin of -24.85%. Masimo's return on equity of 26.54% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Masimo	-24.85%	26.54%	11.49%
Omnicell	2.01%	4.27%	2.44%

Which has higher valuation & earnings, MASI or OMCL?

Omnicell has lower revenue, but higher earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Masimo	$2.09B	3.85	-$304.90M	-$8.52	-17.41
Omnicell	$1.11B	1.28	$12.53M	$0.50	61.96

Summary

Masimo beats Omnicell on 11 of the 17 factors compared between the two stocks.